Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/24/2025

Management of Subclinical Hypothyroidism in Pregnancy

Assessment and Diagnosis

  • A TSH level of 10.6 mIU/L exceeds the threshold of 10 mIU/L that warrants treatment regardless of symptoms, according to the American Medical Association 4, 5
  • Normal T4 confirms the diagnosis of subclinical hypothyroidism, as stated by the American Medical Association 6
  • Normal TPO antibodies indicate that this is not clearly autoimmune thyroiditis, but this does not change the management approach in pregnancy, as noted by the American Medical Association 6, 7

Treatment Recommendations

  • The American Medical Association recommends initiating levothyroxine therapy immediately to restore serum TSH to the reference range in pregnant women with subclinical hypothyroidism 1, 2
  • Maternal hypothyroidism during pregnancy is associated with higher rates of serious complications, including spontaneous abortion, gestational hypertension, pre-eclampsia, and stillbirth, as reported by the American College of Physicians 8 and the American Medical Association 2
  • Untreated maternal hypothyroidism may adversely affect fetal neurocognitive development, according to the American Medical Association 2
  • Even subclinical hypothyroidism with TSH >10 mIU/L has a 5% rate of progression to overt hypothyroidism, and treatment may prevent manifestations of hypothyroidism in those who progress, as stated by the American Medical Association 1, 5

Rationale for Treatment

  • The American Medical Association recommends treatment due to the potential benefit-risk ratio that strongly favors treatment in pregnant women, even without intervention trials specifically in this population 2, 3
  • The risks of appropriately managed levothyroxine therapy in pregnancy are minimal compared to the potential benefits, as noted by the American Medical Association 2
  • While some studies show that 37% of subclinical hypothyroidism cases may spontaneously resolve, the risks of non-treatment in pregnancy outweigh the benefits of waiting, especially with TSH >10 mIU/L, as reported by the American College of Physicians 8 and the American Medical Association 2, 3

Special Considerations

  • Excessive levothyroxine can lead to subclinical hyperthyroidism, which occurs in 14-21% of treated patients, according to the American Medical Association 5, 3
  • The American Medical Association advises against delaying treatment while waiting for symptoms to develop or for overt hypothyroidism to manifest, as this could harm both mother and fetus 2, 3